Progestin-only contraceptive
This page covers all Progestin-only contraceptive drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Progesterone receptor.
Targets
Marketed (1)
- Implanon® · FHI 360 · Contraception
Implanon® releases a steady dose of the progestin etonogestrel subdermally to prevent ovulation and thicken cervical mucus, providing long-acting reversible contraception.
Phase 3 pipeline (2)
- Radiopaque Etonogestrel Implant · Organon and Co · Contraception / Women's Health
A subdermal contraceptive implant that releases etonogestrel (a progestin) to prevent ovulation and thicken cervical mucus, with added radiopaque material for improved visibility on imaging. - Radiopaque Implanon · Organon and Co · Contraception
Radiopaque Implanon is a subdermal contraceptive implant containing etonogestrel that provides long-acting reversible contraception by suppressing ovulation through progestin delivery.